Oct. 1, 2018 /CNW/ - FIGR Inc. is pleased to announce its subsidiary, Goldleaf Pharm Inc. received its Access to Cannabis for Medical Purposes Regulations (ACMPR) cultivation license from Health Canada on September 28, 2018. With this license, Goldleaf Pharm is permitted to begin cultivating medicinal cannabis at its facility, located in Simcoe, Ontario.
Read more
FIGR Inc. subsidiary receives ACMPR cannabis cultivation license from Health Canada
